Skip to main content
SpringerLink
Log in

Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Several trials demonstrated that a long detection interval and a high-rate cutoff reduced implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients. However, only a few data are available for secondary prevention (SP) patients. The aim of this study was to evaluate whether these ICD programming would be effective in reducing ICD therapies in SP patients. We enrolled 65 SP patients under ICD or cardiac resynchronization therapy with the defibrillator programmed with the same setting (conventional setting). During follow-up, we changed detection rates in each zone; cycle length (CL) ≤400 to ≤370 ms for ventricular tachycardia (VT) zone, CL ≤350 to ≤320 ms for fast VT zone, CL ≤300 to ≤270 ms for ventricular fibrillation (VF) zone, and number of intervals to detect ventricular tachyarrhythmia in VF zone: 12–24. We retrospectively compared the incidences of ICD therapies, syncope, and hospitalization due to slow VT under the detection rate between both settings. Median follow-up periods were 5.0 (interquartile range 2.5–7.8) and 2.5 years (interquartile range 2.3–2.7) in conventional and strategic settings, respectively. The incidence of appropriate ATP and shock significantly decreased in strategic setting (conventional and strategic settings: 21.2 and 4.8 ATPs per year, respectively, OR 0.18, 95 % CI 0.06–0.54, p = 0.002, 26.1 and 7.8 shocks per year, respectively, OR 0.29, 95 % CI 0.09–0.88, p = 0.03). The incidence of overall inappropriate therapy significantly decreased (conventional and strategic settings: 17.6 and 2.8 therapies per year, respectively, OR 0.14, 95 % CI 0.05–0.44, p = 0.01). The incidence of syncope and slow VT was not significantly different between both settings. In conclusion, ICD programming-combined long detection interval with high-rate cutoff was effective in reducing appropriate shock and inappropriate therapy without increasing the incidence of syncope and slow VT in SP patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237

    Article  CAS  PubMed  Google Scholar 

  3. The antiarrhythmics versus implantable defebrillators investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337:1576–1583

    Article  Google Scholar 

  4. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ (2008) Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51:1357–1365

    Article  PubMed  Google Scholar 

  6. Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-Brunetto A, Babuty D (2014) Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized option study. JACC. Heart fail 2(6):611–619

    Article  PubMed  Google Scholar 

  7. Knackstedt C, Arndt M, Mischke K, Marx N, Nieman F, Kunert HJ, Schauerte P, Norra C (2014) Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy. Heart Vessels 29:364–374

    Article  PubMed  Google Scholar 

  8. Ruwald AC, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, Cannom DS, Estes NA, Ruwald MH, Huang DT, Klein H, McNitt S, Beck CA, Goldstein R, Brown MW, Kautzner J, Shoda M, Wilber D, Zareba W, Daubert JP (2014) Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol 7:785–792

    Article  PubMed  Google Scholar 

  9. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367:2275–2283

    Article  CAS  PubMed  Google Scholar 

  10. Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, Hersi A, Gulaj M, Wijfels MC, Santi E, Manotta L, Arenal A (2013) Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA 309:1903–1911

    Article  CAS  PubMed  Google Scholar 

  11. Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C (2014) Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol 25:52–59

    Article  PubMed  Google Scholar 

  12. Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV (2014) Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 7:164–170

    Article  PubMed  Google Scholar 

  13. Kloppe A, Proclemer A, Arenal A, Lunati M, Martinez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M (2014) Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial. Circulation 130:308–314

    Article  CAS  PubMed  Google Scholar 

  14. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ (2004) Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE RX II) trial results. Circulation 110:2591–2596

    Article  PubMed  Google Scholar 

  15. Wilkoff BL, Hess M, Young J, Abraham WT (2004) Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 15:1002–1009

    Article  PubMed  Google Scholar 

  16. Kutyifa V, Daubert JP, Olshansky B, Huang DT, Zhang C, Ruwald AC, McNitt S, Zareba W, Moss AJ, Schuger C (2015) Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: result of the MADIT-RIT efficacy analysis. Heart Rhythm 12(9):2030–2037

    Article  PubMed  Google Scholar 

  17. Sadoul N, Mletzko R, Anselme F, Bowes R, Schols W, Kouakam C, Casteigneau G, Luise R, Iscolo N, Aliot E (2005) Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation 112:946–953

    Article  PubMed  Google Scholar 

  18. Ruwald MH, Abu-Zeitone A, Jons C, Ruwald AC, McNitt S, Kutyifa V, Zareba W, Moss AJ (2013) Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). J Am Coll Cardiol 62:1343–1350

    Article  CAS  PubMed  Google Scholar 

  19. Lee CH, Nam GB, Park HG, Kim HY, Park KM, Kim J, Choi KJ, Kim YH (2008) Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators. Circ J 72:102–105

    Article  CAS  PubMed  Google Scholar 

  20. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH, Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients in Cardioverter Defibrillator Patients (OPTIC) Investigators (2006) Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 295:165–171

    Article  CAS  PubMed  Google Scholar 

  21. Suzuki A, Yoshida A, Takei A, Fukuzawa K, Kiuchi K, Takami K, Itoh M, Imamura K, Fujiwara R, Nakanishi T, Yamashita S, Matsumoto A, Shimane A, Okajima K, Hirata K (2015) Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: clinical outcomes after a single endocardial ablation. Journal of arrhythmia 31:122–129

    Article  PubMed  PubMed Central  Google Scholar 

  22. Patel D, Hasselblad V, Jackson KP, Pokorney SD, Daubert JP, Al-Khatib SM (2016) Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials. J Interv Card Electrophysiol 45:111–117

    Article  PubMed  Google Scholar 

  23. Miyamoto K, Noda T, Satomi K, Wada M, Nakajima I, Ishibashi K, Okamura H, Noguchi T, Anzai T, Yasuda S, Ogawa H, Shimizu W, Aiba T, Kamakura S, Kusano K (2015) Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation. Heart Vessels. doi:10.1007/s00380-015-0732-7

    Google Scholar 

  24. Yokoshiki H, Mitsuyama H, Watanabe M, Mizukami K, Tsutsui H (2014) Suppression of ventricular fibrillation by electrical modification of the purkinje system in hypertrophic cardiomyopathy. Heart Vessels 29:709–717

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. M. Fukui for his statistical advice.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan

    Yusuke Hayashi, Masahiko Takagi, Jun Kakihara, Shogo Sakamoto, Atsushi Doi, Kenichi Sugioka, Akihisa Hanatani & Minoru Yoshiyama

Authors
  1. Yusuke Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masahiko Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jun Kakihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shogo Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Atsushi Doi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenichi Sugioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Akihisa Hanatani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Minoru Yoshiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masahiko Takagi.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hayashi, Y., Takagi, M., Kakihara, J. et al. Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients. Heart Vessels 32, 175–185 (2017). https://doi.org/10.1007/s00380-016-0850-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-016-0850-x

Keywords

Search

Navigation